AlbionVC closes £90M oversubscribed VCT raise for UK deeptech and healthcare

What's the deal? London-based AlbionVC has closed a £90M oversubscribed top-up offer across its three Venture Capital Trusts (VCTs), surpassing an initial £60M target. A £30M overallotment facility was triggered in December 2025 due to excess demand. Capital will go into UK high-growth companies in deeptech, healthcare, and B2B software.

Why now? The raise lands amid strong portfolio momentum. Over the past five years, the Albion VCTs have raised over £405M; in the past three years, 64% of portfolio companies advanced from growth stage to scaleup. Tax efficiency is also a tailwind: VCTs offer 30% income tax relief, tax-free dividends, and capital gains tax exemption — a compelling pitch in a high-tax environment.

Notable holdings include Quantexa, the global leader in decision intelligence; Oviva, Europe's leading digital health company for weight loss, which raised a £200M Series D; and tem, an AI-powered infrastructure platform cutting energy costs for businesses.

What could go wrong? VCTs concentrate risk in early- and growth-stage UK companies, which are more exposed to economic downturns, rising interest rates, and tighter enterprise spending. Tax relief rules are also subject to regulatory change — any government adjustment to VCT incentives could dampen future investor appetite.

The signal: The oversubscribed close — in a market where many funds struggle to hit targets — signals durable investor appetite for tax-efficient vehicles that channel capital into UK tech.

With £1B in assets under management, AlbionVC is positioning for more fundraising and exits. As the UK government pushes to cement the country as a science and technology superpower, VCTs are quietly becoming a structural pillar of that ambition.

Sources:
AlbionVC
Startup Researcher
The Realpreneur
Tech Funding News
GlobeNewswire 
Tech.eu

Image source:
AlbionVC

J.V.